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In vitro biofilm assembly
Biofilm carachterization
Biofilm phenotype / bacteria genome
Antimicrobial Resistance Surveillance in Europe 2015 (Jan-2017)
Percentage of Klebsiella pneumoniae isolates
non-susceptible to fluorquinolones in HAIs in 
acute hospitals
Antibiotic 2012 2013 2014 2015 Trend
2012-2015
N %R (95%C) N %R (95%C) N %R (95%C) N %R (95%C)
Fluorquinolones
(F)




781 38,7 (35-42) 911 37,0 (34-40) 1712 40,9 (39-43) 2094 40,4 (38-43)
Aminoglicosides
(A)
780 31,8 (29-35) 912 29,4 (26-32) 1706 30,5 (28-33) 2090 32,6 (31-35)




776 25,1 (22-28) 909 21,7 (19-24) 1705 22,8 (21-25) 2084 25,0 (23-27)
Healthcare-associated infections
(HAI) are a major public health
problem.
2.6 million cases in long-term care
facilities; 4.1 million cases in acute-
care hospitals, which result in 37,000
annual deaths in Europe per year.
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Klebsiella pneumoniae biofilms
Strain Source Year Serologic
group
Fimbriae β-lactamases
Kp45 Neck swab 1980 K:2 fimH mrkD TEM-1
Kp26 Rectal swab K:2 n.a. n.a. TEM-1
Kp703 Urine O:1 n.a. mrkD TEM-1
Kp3921 2010 n.a. fimH mrkD CTX-M-15
Kp2948 Wound K:2 fimH mrkD KPC-3; TEM-1
Kp3421 Urine 2011 n.a. fimH mrkD CTX-M-15
Kp3407 n.a. fimH mrkD KPC-3
Kp3466 n.a. n.a. n.a. TEM-163
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ic K. pneumoniae 45 250 0,781 3.05 500
K.pneumoniae 703O:1 250 < 0.488 0,76 500





K. pneumoniae 45 > 2500 0,781 24.4 ND
K.pneumoniae 703O:1 > 2500 500 195 ND





. i  10 = 8
K.pneumoniae 703O:1 10 1000 257 ND
K.pneumoniae 2948 5 = 2 ND




Nucleotide similarity above 99.5%
(20172/5151664 variant sites)
 
Table 1. Genetic differences in the accessory genome of the K. pneumoniae isolates. 
    
Genomic Approximate Isolate  
region 1 length (Kbp) Kp703 Kp45 Kp2948 Relevant information 2,3 
1 45 v --- --- Intact prophage (predicted by PHAST) 
2 41 v --- --- Intact prophage (predicted by PHAST) 
3 4 v --- --- Includes predicted AMR genes: tetracycline resistance genes tet(A/G) and tetR 
4 6 v --- --- Includes Ribose ABC-transporter system proteins (permease RbsC, ATP-binding RbsA) 
5 11 v --- --- Includes genes encoding a Filamentous hemagglutinin and a Hemolysin transporter protein.  
6 57 v --- --- Includes genes encoding a Haemolysin expression modulating protein, the YdeA protein and a Programmed cell death antitoxin MazEF 
7 12 v --- --- Putative prophage elements: predicted annotation includes several hypothetical proteins, a purine NTPase and a prophage CP4-57 integrase 
8 2 v v --- Aerotaxis sensor receptor protein 
9 13 v v --- Includes an additional Urea ABC transport system (another similar gene cluster is carried by all three isolates)  
10 4 36 v --- --- Incomplete prophage (predicted by PHAST) carrying a strain-specific Glycosaminoglycan attachment site encoding gene 
11 4 36 --- v --- Incomplete prophage (predicted by PHAST) carrying a strain-specific Transcription activator gutR gene 
12 12 --- v v Putative plasmid fragments carrying the virulence-associated proteins VagC and VagD.  
13 37 --- v --- Intact prophage (predicted by PHAST) 
14 43 --- v --- Intact prophage (predicted by PHAST) 
15 57 v --- v Includes genes encoding Type IV pili-related proteins, a TonB-dependent protein, Iron aquisition yersiniabactin synthesis enzymes; and a predicted AMR gene likely associated with 
resistance to tetracycline and aminoglycosides (fyuA)   
16 2 v --- v Includes a predicted AMR gene: blaTEM-1A - class A beta-lactamase  
17 13 --- v v Includes genes encoding Type I secretion related proteins (LapC, ATPase LapB, LapE, agglutinin RTX). 
18 7 --- v v Includes predicted AMR genes: Aminoglycoside 3'-phosphotransferase strA and strB [or APH(3'')-Ib and APH(6)-Id, respectively] likely associated with resistance to aminoglycosides. 
19 11 --- v --- Predicted annotation includes several hypothetical proteins and putative phage-like elements. 
20 39 --- v --- Intact prophage (predicted by PHAST) 
21 17 --- --- v Questionable prophage (predicted by PHAST) 
22 11 --- --- v Incomplete prophage (predicted by PHAST) 
23 40 --- --- v Intact prophage (predicted by PHAST)  
24 25 --- --- v Questionable prophage (predicted by PHAST)  
25 37 --- --- v Questionable prophage (predicted by PHAST)  
26 12 --- --- v Incomplete prophage (predicted by PHAST) 
27 5 --- --- v Includes genes encoding a putative serine protease (from the Peptidase S8 Subtilisin superfamily) and a cell division protein FtsH. 
 
28 27 --- --- v Putative fragment of a conjugative plasmid including genes encoding Type IV pili-related proteins, a Programmed cell 
death antitoxin MazE and a zinc metalloproteinase Mpr protein. 
29 1 --- --- v Includes a predicted AMR gene: trimetroprim resistance gene dfrA14 coding for a Dihydrofolate reductase 
30 40 --- --- v Intact prophage (predicted by PHAST)  
31 4 --- --- v Includes predicted AMR genes: tetracycline resistance genes tet(A/G)and tetR; and proteins from the Glutathione-dependent 
pathway of formaldehyde detoxification 
32 17 --- --- v Includes a predicted AMR gene (KPC-3  beta-lactam resistance gene) and gene encoding a Chromate resistance protein 
ChrB 
33 22 --- --- v Includes genes coding for a arsenic resistance operon and a outer membrane protein or related peptidoglycan-associated 
(lipo)protein 
34 5 --- --- v Includes genes coding for a phosphonate ABC transport system and the RuBisCO operon transcriptional regulator CbbR 
35 1 --- --- v Includes a predicted AMR gene: SHV-161  beta-lactam resistance gene  
36 3 --- --- v Includes a predicted AMR gene: AC(6')-Ib putative fluoroquinolone resistance gene. 
37 2 --- --- v Includes a predicted AMR gene: putative Sulphonamide 
 resistance gene sul1 coding for a Dihydropteroate synthase  
38 1 --- --- v Includes a predicted AMR gene: putative Sulphonamide 
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